Respiratorius AB (XSAT:RESP) Short Interest

View and export this data going back to 2012. Start your Free Trial

What is Respiratorius AB Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Respiratorius AB's Short Interest

For the Biotechnology subindustry, Respiratorius AB's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Respiratorius AB's Short Interest Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Respiratorius AB's Short Interest distribution charts can be found below:

* The bar in red indicates where Respiratorius AB's Short Interest falls into.

Save Embed

;

Save Embed

;

Respiratorius AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Respiratorius AB (XSAT:RESP) » Definitions » Short Interest

Comparable Companies

Traded in Other Exchanges

N/A

Address

Scheelevagen 2, Medicon Village, Lund, SWE, 223 81

Website

https://www.respiratorius.com

Respiratorius AB develops pharmaceutical drugs to treat the common diseases namely Cancer, Chronic Obstructive Pulmonary Disease (COPD), and asthma as well as better methods for diagnosing cardiovascular diseases. The company's drug candidates includes RCD405, VAL001, RESP2000, RESP3000, RESP9000, and RESP1000.

Respiratorius AB Headlines

No Headlines